Blog - Page 521 of 5683 - QualityStocks

MondayApr 01, 2024 1:51 pm

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Begins Manufacturing for Major Sports Brand Licensee

Nutriband (NASDAQ: NTRB, NTRBW), a pharmaceutical company with a specific focus on transdermal technologies, today announced it has been engaged by and received a first order from Fit For Life Group (“FFL”), a major brand license holder. Nutriband expects a fully executed supplier agreement to follow. Under the agreement Nutriband’s wholly owned contract manufacturing subsidiary, Active Intelligence, will act as manufacturer. “This purchase order from FFL allows Nutriband and our contract manufacturing subsidiary, Active Intelligence, to once again demonstrate our capabilities in the development and manufacturing of innovative products,” said Gareth Sheridan, CEO of Nutriband. “We are excited to continue…

MondayApr 01, 2024 12:00 pm

20th BioPharma Clinical Trials Nexus Conference: Exploring the Clinical Trials Ecosystem

Industry experts, entrepreneurs, investors, clinical operations professionals, regulatory affairs experts, data scientists, and technology innovators from the pharma industry, are invited to attend the 20th BioPharma Clinical Trials Nexus Conference being held on May 8-9, 2024, in Sheraton Mission Valley San Diego Hotel, San Diego. The exclusive BioPharma Clinical Trials Nexus, accessible only by invitation, brings together prominent solution providers and clinical trial executives under one roof. As a prestigious two-day event, the conference content is carefully curated for two days of collaboration and immersive learning. This mega networking conference provides attendees with ample opportunities to meet industry pioneers and…

MondayApr 01, 2024 11:15 am

NECANN Maryland Cannabis Convention & Expo 2024, Baltimore, MD

Entrepreneurs, influencers, advocates, patients, investors, service providers, educators, and consumers of the cannabis spectrum, are all invited to attend the first-ever Cannabis Convention of Maryland that focuses on networking, learning, and discovering new cannabis products and services for the greater Maryland community. NECANN organizes the foremost cannabis events, with a robust platform for cannabis enthusiasts to connect with industry experts and peers, presenting critical knowledge to expand businesses. NECANN has offered growth opportunities to the local communities throughout the northeast and beyond since 2014. It has boosted the cannabis economy by creating a hub of resources and communication available to…

MondayApr 01, 2024 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Upcoming Fourth Quarter Financial Results and Conference Call

D-Wave will release its financial results for the fourth quarter and fiscal year 2023 before market open on Thursday, March 28, 2024 D-Wave will host a conference call on March 28, 2024, at 8:00 a.m. (Eastern Time) to address the company’s financial performance and strategic outlook CEO Alan Baratz and CFO John Markovich will participate in the conference call discussion D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, recently announced the scheduled release of its financial results for the fourth quarter and fiscal year 2023, which concluded on December 31, 2023. The release is set…

MondayApr 01, 2024 9:45 am

Turbo Energy S.A. (NASDAQ: TURB) Powering the Future: Tech-Infused Photovoltaics and the Path to Sustainable Energy

The global solar energy market is forecasted by Fortune Business Insights to rise from $3.33 billion in 2022 to over $20 billion by 2030 Turbo Energy S.A. will be part of the explosive growth, as tech-infused photovoltaics become instrumental in more efficient use of solar energy Turbo Energy S.A. is a leader in the residential markets in Spain, offering a complete lineup of Li-ion batteries, inverters, software, and their turnkey product, Sunbox The world is facing a critical juncture. Our dependence on fossil fuels has demonstrably contributed to climate change, necessitating a global shift towards cleaner, more sustainable energy sources.…

MondayApr 01, 2024 9:00 am

Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference

Sigyn Therapeutics CEO Jim Joyce reviewed the company’s pipeline of technologies, including ChemoPrep(TM), ChemoPure(TM), and ImmunePrep(TM) to improve patient responses to various cancer therapies, and Sigyn Therapy(TM) to address drug resistant viral and bacterial infections, endotoxemia, and sepsis, a leading cause of hospital deaths in the United States The company created Sigyn Therapy(TM) to treat pathogen-associated disorders that are not addressed with drug therapies Sigyn Therapeutics is developing ChemoPrep(TM) and ImmunePrep(TM), to improve patient responses to chemotherapy and immunotherapeutic antibodies, respectively To reduce toxicity, the company designed ChemoPure(TM) to sweep off-target chemotherapy from the bloodstream before it is able to cause…

ThursdayMar 28, 2024 3:42 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Positioned ‘Ahead of the Curve’ in Tokenization

Diamond Lake Minerals (OTC: DLMI) is a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens. The company was featured in a new Benzinga Crypto article that discussed DLMI’s favorable positioning in tokenization attributed to its innovative technology, infrastructure and leadership. “DLMI has spent a substantial amount of time and resources under the leadership of its CEO Brian J. Esposito working on the program of converting real estate assets into blockchain-based digital tokens in its ecosystem… A big part of DLMI’s strategy was its recent acquisition of Avrio Worldwide PBC, a registered market infrastructure…

ThursdayMar 28, 2024 2:50 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Capitalizing on ‘Overwhelming Interest’ to Focus on GLP-1 Applications of DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that it will focus on glucagon-like peptide 1 (“GLP-1”) applications of its patented DehydraTECH(TM) technology for diabetes and weight loss for the 2024 calendar year. “This comes hot on the heels of a successful, active year of R&D in 2023, a year that saw significant strides in developing its patented DehydraTECH technology including its new foray into GLP-1 drugs… This laid the groundwork for Lexaria to explore a new class of molecules it had never worked on before, ultimately quietly launching its top-priority and unpublicized early-stage…

ThursdayMar 28, 2024 9:45 am

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

Longeveron recently released its full-year results for the period ended December 31, 2023, and provided a corporate update The update outlined the company’s plans to prioritize the development of Lomecel-B(TM) in Hypoplastic Left Heart Syndrome (“HLHS”), a rare, pediatric congenital heart condition characterized by an underdeveloped left side of the heart Longeveron plans to complete the enrollment in the ELPIS II trial for HLHS in 2024 The company also reported that it is exploring opportunities to advance its Alzheimer’s disease program through potential partnerships or other sources of funding Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for…

ThursdayMar 28, 2024 9:00 am

Astrotech Corp. (NASDAQ: ASTC) and AgLAB Inc. Use Mass Spectrometer Technology to Significantly Enhance Hemp and Cannabis Production Yield and Profit

The cannabinoid market value in 2023 was $22.23 billion and is expected to grow at a CAGR of 15.3%, resulting in an estimated market value of $60.36 billion The global mass spectrometry market will reach $6.77 billion in 2024 and is expected to grow at a CAGR of 6.25%, reaching $9.17 billion by 2029. Astrotech and subsidiary AgLAB Inc. are using mass spectrometry to boost the profitable yield of hemp and cannabis production The United States has seen a rising awareness of the health and therapeutic benefits of cannabinoids, prompting an expected market increase of 15.3%, from $22.23 billion in…

Site Search

Company Search